
### [MONDO:0017690](http://purl.obolibrary.org/obo/MONDO_0017690)
**Label:** disorder of galactose metabolism

**Subclasses:** [MONDO:0018116](http://purl.obolibrary.org/obo/MONDO_0018116) (galactosemia), [MONDO:0009257](http://purl.obolibrary.org/obo/MONDO_0009257) (galactose epimerase deficiency), 

**Corr. equiv. classes:** [Orphanet:352](http://www.orpha.net/ORDO/Orphanet_352), [Orphanet:79238](http://www.orpha.net/ORDO/Orphanet_79238), [OMIM:230350](http://purl.obolibrary.org/obo/OMIM_230350), 

**Class expressions from DL-Learner:**

- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0012072](http://purl.obolibrary.org/obo/HP_0012072) (Aciduria) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 83.33%
- [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 83.33%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0003355](http://purl.obolibrary.org/obo/HP_0003355) (Aminoaciduria) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0002017](http://purl.obolibrary.org/obo/HP_0002017) (Nausea and vomiting) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0001744](http://purl.obolibrary.org/obo/HP_0001744) (Splenomegaly) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0001743](http://purl.obolibrary.org/obo/HP_0001743) (Abnormality of the spleen) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%
- [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0004915](http://purl.obolibrary.org/obo/HP_0004915) (Impairment of galactose metabolism) 83.33%


